From target to clinic. Every stage. One platform.
Set a direction — the platform identifies targets, validates against clinical evidence, optimizes leads, docks candidates, predicts clinical clearance, and stratifies patients. Nine autonomous stages. One conversation.
Target Discovery
108K associations
Literature & Landscape
14K papers · 2.4M actives
ADMET Profiling
122M profiled · <50ms
Compliance
8 jurisdictions · inline
Lead Optimization
30+ scaffolds
Molecular Docking
AutoDock-GPU · PLIP
Clinical Outcomes
AUROC 0.756
MD Simulation
GROMACS · MM-GBSA
Patient Stratification
56 pharmacogenes
Target Discovery
108K associations
Literature & Landscape
14K papers · 2.4M actives
ADMET Profiling
122M profiled · <50ms
Compliance
8 jurisdictions · inline
Lead Optimization
30+ scaffolds
Molecular Docking
AutoDock-GPU · PLIP
Clinical Outcomes
AUROC 0.756
MD Simulation
GROMACS · MM-GBSA
Patient Stratification
56 pharmacogenes
The discovery funnel
Each stage has its own page with the science problem, proof, and a one-sentence prompt.
Target Discovery
108,000 omics-derived target-disease associations ranked by composite evidence score.
Literature & Landscape
14,000 papers, 2,400 patents, 2.4M ChEMBL compounds, 500K clinical trials — one query.
ADMET Profiling
122M compounds pre-profiled. 41 ML models. NovoExpert-2 SOTA on 5 TDC endpoints.
Compliance
FAVES V4 — 8 jurisdictions, 1,585 structural alert patterns. Inline at every stage.
Lead Optimization
Scaffold hopping + MolMIM AI optimization. Every variant auto-enriched with ADMET and compliance.
Molecular Docking
AutoDock-GPU with PLIP contact analysis and GFN2-xTB strain energy validation.
Clinical Outcomes
NovoExpert-3 Phase I clearance prediction. AUROC 0.756. SHAP explanations.
MD Simulation
GROMACS GPU with MM-GBSA. Membrane pipeline. AlphaFlow dynamics fallback.
Patient Stratification
56 pharmacogenes, 135K ClinVar resistance variants, population pharmacogenomics.
Start a discovery pipeline
Nine stages. One conversation. Sign up and run your first funnel.